JPWO2023086834A5 - - Google Patents
Info
- Publication number
- JPWO2023086834A5 JPWO2023086834A5 JP2024528467A JP2024528467A JPWO2023086834A5 JP WO2023086834 A5 JPWO2023086834 A5 JP WO2023086834A5 JP 2024528467 A JP2024528467 A JP 2024528467A JP 2024528467 A JP2024528467 A JP 2024528467A JP WO2023086834 A5 JPWO2023086834 A5 JP WO2023086834A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- endonuclease
- target nucleic
- cell
- presynthesized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163278886P | 2021-11-12 | 2021-11-12 | |
| US63/278,886 | 2021-11-12 | ||
| US202263341200P | 2022-05-12 | 2022-05-12 | |
| US63/341,200 | 2022-05-12 | ||
| PCT/US2022/079567 WO2023086834A1 (en) | 2021-11-12 | 2022-11-09 | Direct replacement genome editing |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024543481A JP2024543481A (ja) | 2024-11-21 |
| JP2024543481A5 JP2024543481A5 (https=) | 2025-11-13 |
| JPWO2023086834A5 true JPWO2023086834A5 (https=) | 2025-11-13 |
Family
ID=86324212
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024528467A Pending JP2024543481A (ja) | 2021-11-12 | 2022-11-09 | 直接置き換えゲノム編集 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20230151353A1 (https=) |
| EP (1) | EP4430207A4 (https=) |
| JP (1) | JP2024543481A (https=) |
| AU (1) | AU2022387615A1 (https=) |
| CA (1) | CA3237317A1 (https=) |
| IL (1) | IL312727A (https=) |
| MX (1) | MX2024005787A (https=) |
| WO (1) | WO2023086834A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024233949A1 (en) * | 2023-05-11 | 2024-11-14 | Replace Therapeutics, Llc | Revision of genetic material using direct replacement editing |
| AU2024344127A1 (en) * | 2023-09-22 | 2026-04-02 | Revision Bio Corporation | Dna ligase compositions, methods, and uses thereof |
| AU2024347035A1 (en) * | 2023-09-22 | 2026-04-02 | Revision Bio Corporation | Dna-dependent dna polymerase compositions, methods, and uses thereof |
| WO2025226730A1 (en) * | 2024-04-22 | 2025-10-30 | Transit Therapeutics, Inc. | Revision of genetic material using direct replacement editing |
| WO2025235828A2 (en) * | 2024-05-08 | 2025-11-13 | The General Hospital Corporation | Engineered prime editors for treating genetic deafness |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10221442B2 (en) * | 2012-08-14 | 2019-03-05 | 10X Genomics, Inc. | Compositions and methods for sample processing |
| US20190330659A1 (en) * | 2016-07-15 | 2019-10-31 | Zymergen Inc. | Scarless dna assembly and genome editing using crispr/cpf1 and dna ligase |
| US11649442B2 (en) * | 2017-09-08 | 2023-05-16 | The Regents Of The University Of California | RNA-guided endonuclease fusion polypeptides and methods of use thereof |
| CA3138576A1 (en) * | 2019-05-16 | 2020-11-19 | Trustees Of Boston University | Regulated synthetic gene expression systems |
| US20230008217A1 (en) * | 2019-12-17 | 2023-01-12 | Agilent Technologies, Inc. | Ligation-based gene editing using crispr nickase |
| US20230037794A1 (en) * | 2019-12-23 | 2023-02-09 | The Broad Institute, Inc. | Programmable dna nuclease-associated ligase and methods of use thereof |
| AU2021236683A1 (en) * | 2020-03-19 | 2022-11-17 | Intellia Therapeutics, Inc. | Methods and compositions for directed genome editing |
-
2022
- 2022-11-09 JP JP2024528467A patent/JP2024543481A/ja active Pending
- 2022-11-09 US US17/984,045 patent/US20230151353A1/en not_active Abandoned
- 2022-11-09 AU AU2022387615A patent/AU2022387615A1/en active Pending
- 2022-11-09 WO PCT/US2022/079567 patent/WO2023086834A1/en not_active Ceased
- 2022-11-09 EP EP22893813.0A patent/EP4430207A4/en active Pending
- 2022-11-09 MX MX2024005787A patent/MX2024005787A/es unknown
- 2022-11-09 IL IL312727A patent/IL312727A/en unknown
- 2022-11-09 CA CA3237317A patent/CA3237317A1/en active Pending
-
2025
- 2025-01-27 US US19/037,641 patent/US20250179468A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102919364B1 (ko) | 유전자 편집을 위한 변형된 가이드 rna | |
| US20220307018A1 (en) | ENGINEERED GUIDE RNA FOR THE OPTIMIZED CRISPR/Cas12f1 SYSTEM AND USE THEREOF | |
| Jiang et al. | The structural biology of CRISPR-Cas systems | |
| JP7093728B2 (ja) | 化学的に修飾されたガイドｒｎａを使用する高特異性ゲノム編集 | |
| JP2022017453A5 (https=) | ||
| EP4227412A1 (en) | Engineered guide rna for increasing efficiency of crispr/cas12f1 (cas14a1) system, and use thereof | |
| JP2023518395A (ja) | 指向性ゲノム編集のための方法及び組成物 | |
| AU7406700A (en) | Design of high affinity rnase h recruiting oligonucleotide | |
| EP4227411A1 (en) | Engineered guide rna for increasing efficiency of crispr/cas12f1 system, and use of same | |
| JP5628664B2 (ja) | 相同組換え方法およびクローニング方法並びにキット | |
| IL259788B2 (en) | Adapted nucleic acid sequences, preparations containing them and methods for determining the duplex sequence using them | |
| JPS61181384A (ja) | オリゴヌクレオチドリンカ−とその使用法 | |
| JP2004503207A (ja) | 核酸をライゲーションする方法および分子クローニング | |
| KR20220144343A (ko) | CRISPR/Cas12f1 시스템 효율화를 위한 U-rich tail을 포함하는 엔지니어링 된 가이드 RNA 및 그 용도 | |
| EP4227408A1 (en) | Engineered guide rna comprising u-rich tail for increasing efficiency of crispr/cas12f1 system, and use thereof | |
| US20240254464A1 (en) | Cleavage-inactive cas12f1, cleavage-inactive cas12f1-based fusion protein, crispr gene-editing system comprising same, and preparation method and use thereof | |
| KR20230007218A (ko) | 초소형 염기교정 시스템 및 이의 용도 | |
| JPWO2021102390A5 (https=) | ||
| JP2021522825A5 (https=) | ||
| JPWO2023086834A5 (https=) | ||
| KR102703683B1 (ko) | 유전자 편집을 위한 TaRGET 시스템 및 이의 용도 | |
| Mi | Molecular cloning of protein-based polymers | |
| US20080221315A1 (en) | Nucleic acid-based translation system and method for decoding nucleic acid encrypted message | |
| CN101313067A (zh) | 以rna干扰特异性抑制基因表达的dna构建体 | |
| JP2025078774A (ja) | 連結された標的捕捉 |